| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | SET | 5.49e-04 | 41 | 73 | 3 | PF00856 | |
| Domain | SET | 7.71e-04 | 46 | 73 | 3 | SM00317 | |
| Domain | SET_dom | 9.84e-04 | 50 | 73 | 3 | IPR001214 | |
| Domain | SET | 9.84e-04 | 50 | 73 | 3 | PS50280 | |
| Domain | Post-SET_dom | 1.75e-03 | 16 | 73 | 2 | IPR003616 | |
| Domain | PostSET | 1.75e-03 | 16 | 73 | 2 | SM00508 | |
| Domain | POST_SET | 1.75e-03 | 16 | 73 | 2 | PS50868 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.81e-05 | 65 | 46 | 4 | M39682 | |
| Pubmed | 2.34e-08 | 418 | 75 | 10 | 34709266 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.31e-07 | 351 | 75 | 8 | 38297188 | |
| Pubmed | 2.10e-06 | 529 | 75 | 9 | 14621295 | ||
| Pubmed | A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing. | 4.59e-06 | 2 | 75 | 2 | 30099721 | |
| Pubmed | 7.22e-06 | 57 | 75 | 4 | 18022353 | ||
| Pubmed | 7.35e-06 | 215 | 75 | 6 | 35973513 | ||
| Pubmed | A conserved interaction that is essential for the biogenesis of histone locus bodies. | 1.37e-05 | 3 | 75 | 2 | 25339177 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 28968398 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 21157449 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 32722282 | ||
| Pubmed | FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. | 1.37e-05 | 3 | 75 | 2 | 17245429 | |
| Pubmed | FLASH and NPAT positive but not Coilin positive Cajal Bodies correlate with cell ploidy. | 1.37e-05 | 3 | 75 | 2 | 18677100 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 26768578 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 21725362 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 22028813 | ||
| Pubmed | TEX15 is an essential executor of MIWI2-directed transposon DNA methylation and silencing. | 2.75e-05 | 4 | 75 | 2 | 32719317 | |
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 3.44e-05 | 170 | 75 | 5 | 19064572 | |
| Pubmed | Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models. | 4.57e-05 | 32 | 75 | 3 | 27739607 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 27653681 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 18182036 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.02e-05 | 608 | 75 | 8 | 36089195 | |
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 16100012 | ||
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 1694218 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 9.77e-05 | 861 | 75 | 9 | 36931259 | |
| Pubmed | 1.20e-04 | 44 | 75 | 3 | 27505670 | ||
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 19530321 | ||
| Pubmed | 1.29e-04 | 225 | 75 | 5 | 12168954 | ||
| Pubmed | 1.32e-04 | 226 | 75 | 5 | 31452512 | ||
| Pubmed | 1.39e-04 | 1116 | 75 | 10 | 31753913 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 9922208 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 19531582 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 27609454 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.80e-04 | 934 | 75 | 9 | 33916271 | |
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 1.97e-04 | 52 | 75 | 3 | 30655611 | |
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 18283110 | ||
| Pubmed | 2.11e-04 | 250 | 75 | 5 | 33536335 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.24e-04 | 398 | 75 | 6 | 35016035 | |
| Pubmed | NOL4 KMT2C UBAP2 BRCA1 ZFHX4 KDM2B GPATCH4 MORC2 MGA PRDM2 NPAT | 2.37e-04 | 1429 | 75 | 11 | 35140242 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 2.38e-04 | 139 | 75 | 4 | 25476789 | |
| Pubmed | 2.49e-04 | 11 | 75 | 2 | 31730000 | ||
| Pubmed | 2.49e-04 | 11 | 75 | 2 | 26156989 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.80e-04 | 588 | 75 | 7 | 38580884 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 3.09e-04 | 1005 | 75 | 9 | 19615732 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.38e-04 | 430 | 75 | 6 | 35044719 | |
| Pubmed | 3.52e-04 | 13 | 75 | 2 | 29119051 | ||
| Pubmed | 3.52e-04 | 13 | 75 | 2 | 36379255 | ||
| Pubmed | 3.65e-04 | 64 | 75 | 3 | 20332099 | ||
| Pubmed | 3.67e-04 | 282 | 75 | 5 | 23667531 | ||
| Pubmed | 3.79e-04 | 284 | 75 | 5 | 29459677 | ||
| Pubmed | 4.11e-04 | 14 | 75 | 2 | 22346761 | ||
| Pubmed | NOTCH1 is required for regeneration of Clara cells during repair of airway injury. | 4.73e-04 | 15 | 75 | 2 | 22331706 | |
| Pubmed | 5.34e-04 | 1084 | 75 | 9 | 11544199 | ||
| Pubmed | 5.40e-04 | 16 | 75 | 2 | 20301772 | ||
| Pubmed | Candidate genes and their regulatory elements: alcohol preference and tolerance. | 6.11e-04 | 17 | 75 | 2 | 16783646 | |
| Pubmed | 6.44e-04 | 486 | 75 | 6 | 20936779 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 6.61e-04 | 321 | 75 | 5 | 32098917 | |
| Pubmed | 6.87e-04 | 18 | 75 | 2 | 29329290 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.23e-04 | 497 | 75 | 6 | 36774506 | |
| Pubmed | 7.66e-04 | 19 | 75 | 2 | 31084574 | ||
| Pubmed | 8.44e-04 | 339 | 75 | 5 | 30415952 | ||
| Pubmed | Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. | 8.50e-04 | 20 | 75 | 2 | 17082620 | |
| Pubmed | 8.50e-04 | 20 | 75 | 2 | 33397958 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 9.38e-04 | 21 | 75 | 2 | 27626377 | |
| Pubmed | Candidate genes and cerebral palsy: a population-based study. | 9.38e-04 | 21 | 75 | 2 | 18977990 | |
| Pubmed | Signaling via Alk5 controls the ontogeny of lung Clara cells. | 9.38e-04 | 21 | 75 | 2 | 20147383 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 9.85e-04 | 351 | 75 | 5 | 20453000 | |
| Pubmed | 1.01e-03 | 204 | 75 | 4 | 20503287 | ||
| Pubmed | 1.03e-03 | 205 | 75 | 4 | 19258923 | ||
| Pubmed | 1.03e-03 | 22 | 75 | 2 | 12871600 | ||
| Pubmed | 1.03e-03 | 22 | 75 | 2 | 12768436 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.04e-03 | 954 | 75 | 8 | 36373674 | |
| Pubmed | 1.06e-03 | 207 | 75 | 4 | 17703412 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.08e-03 | 208 | 75 | 4 | 33230847 | |
| Pubmed | 1.21e-03 | 549 | 75 | 6 | 38280479 | ||
| Pubmed | 1.23e-03 | 24 | 75 | 2 | 19584346 | ||
| Pubmed | Ezh2 represses the basal cell lineage during lung endoderm development. | 1.23e-03 | 24 | 75 | 2 | 25516972 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.32e-03 | 1489 | 75 | 10 | 28611215 | |
| Pubmed | KMT2C SETD2 BRCA1 AKAP17A GORAB KDM2B GPATCH4 MARK2 MORC2 SMG6 | 1.38e-03 | 1497 | 75 | 10 | 31527615 | |
| Pubmed | 1.38e-03 | 222 | 75 | 4 | 37071664 | ||
| Pubmed | 1.38e-03 | 101 | 75 | 3 | 9872452 | ||
| Pubmed | 1.42e-03 | 102 | 75 | 3 | 11214970 | ||
| Pubmed | 1.44e-03 | 26 | 75 | 2 | 21054877 | ||
| Pubmed | 1.46e-03 | 103 | 75 | 3 | 10819331 | ||
| Pubmed | Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. | 1.67e-03 | 28 | 75 | 2 | 19661089 | |
| Interaction | PAX2 interactions | 1.42e-05 | 85 | 73 | 5 | int:PAX2 | |
| Interaction | NUP43 interactions | GPALPP1 CASP8AP2 SETD2 BRCA1 GPATCH4 MORC2 MGA PRDM2 TASOR2 KNL1 NPAT | 1.45e-05 | 625 | 73 | 11 | int:NUP43 |
| Interaction | TERF2IP interactions | 2.89e-05 | 552 | 73 | 10 | int:TERF2IP | |
| Interaction | KDM1A interactions | CASP8AP2 NOL4 FLNB AKAP9 BRCA1 ZFHX4 UCHL1 KDM2B MGA PRDM2 KNL1 NPAT NIN | 2.95e-05 | 941 | 73 | 13 | int:KDM1A |
| Interaction | ASF1A interactions | 3.29e-05 | 249 | 73 | 7 | int:ASF1A | |
| Interaction | DHX40 interactions | 3.29e-05 | 249 | 73 | 7 | int:DHX40 | |
| Interaction | PHF21A interactions | 3.33e-05 | 343 | 73 | 8 | int:PHF21A | |
| Interaction | CTCFL interactions | 7.54e-05 | 62 | 73 | 4 | int:CTCFL | |
| Interaction | SNRNP40 interactions | GPALPP1 CASP8AP2 SETD2 BRCA1 AKAP17A GPATCH4 MGA TASOR2 KNL1 NPAT | 9.58e-05 | 637 | 73 | 10 | int:SNRNP40 |
| Cytoband | 4q35.1 | 2.88e-05 | 36 | 75 | 3 | 4q35.1 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.30e-05 | 34 | 39 | 3 | 487 | |
| GeneFamily | PHD finger proteins | 9.58e-04 | 90 | 39 | 3 | 88 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.77e-03 | 29 | 39 | 2 | 396 | |
| GeneFamily | Ubiquitin specific peptidases | 6.49e-03 | 56 | 39 | 2 | 366 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.92e-03 | 181 | 39 | 3 | 694 | |
| GeneFamily | EF-hand domain containing | 1.16e-02 | 219 | 39 | 3 | 863 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 7.02e-06 | 387 | 73 | 9 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.11e-05 | 97 | 73 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.20e-05 | 192 | 73 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | USP53 KMT2C SYCP2 BRCA1 FNIP1 TEX15 CAPS2 MGA CFAP97 TASOR2 NPAT | 6.52e-05 | 776 | 73 | 11 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.67e-05 | 127 | 73 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.63e-05 | 311 | 73 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 9.89e-05 | 134 | 73 | 5 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 CASP8AP2 OGFRL1 SETD2 AKAP9 BRCA1 FNIP1 PRR14L POLQ RFX4 KNL1 | 1.20e-04 | 831 | 73 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 CASP8AP2 OGFRL1 SP100 SETD2 AKAP9 BRCA1 UCHL1 PLCH2 POLQ RFX4 KNL1 | 1.30e-04 | 989 | 73 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.63e-04 | 90 | 73 | 4 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 3.06e-04 | 498 | 73 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 3.17e-04 | 778 | 73 | 10 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.24e-04 | 780 | 73 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 3.34e-04 | 783 | 73 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 3.39e-04 | 382 | 73 | 7 | gudmap_developingGonad_e14.5_ ovary_500 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.74e-08 | 200 | 75 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.01e-06 | 70 | 75 | 4 | 2121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.01e-06 | 70 | 75 | 4 | cd6bca68fe52f451716fc8c0b1745984bc9ec057 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.01e-06 | 70 | 75 | 4 | be300c0447735aba89df4c3082b81eb5abf22770 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 164 | 75 | 5 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-05 | 171 | 75 | 5 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.37e-05 | 181 | 75 | 5 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 184 | 75 | 5 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.64e-05 | 188 | 75 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 188 | 75 | 5 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 1.96e-05 | 195 | 75 | 5 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.96e-05 | 195 | 75 | 5 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 2.01e-05 | 196 | 75 | 5 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-05 | 197 | 75 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.06e-05 | 197 | 75 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.16e-05 | 199 | 75 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-05 | 200 | 75 | 5 | 4f7be296be0cd54cfc62cc93263fde26210c61f4 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-05 | 142 | 75 | 4 | a88bf4bcc80206b16dcc504cc19a3380d01e34a4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.71e-05 | 142 | 75 | 4 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 150 | 75 | 4 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | Control-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 1.23e-04 | 151 | 75 | 4 | 25e7a42989faa01cd41f45b8563725556a5b0cab | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 157 | 75 | 4 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 159 | 75 | 4 | ae53ab7a1339007d0b245c6c291ac61e5ff5b682 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-04 | 163 | 75 | 4 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 165 | 75 | 4 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.77e-04 | 166 | 75 | 4 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.90e-04 | 169 | 75 | 4 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 169 | 75 | 4 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-04 | 169 | 75 | 4 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.90e-04 | 169 | 75 | 4 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 170 | 75 | 4 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 170 | 75 | 4 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 171 | 75 | 4 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 171 | 75 | 4 | f047a0cc2ce0a062ec502aa9cb91b1202f437f29 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-04 | 173 | 75 | 4 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-04 | 173 | 75 | 4 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 2.07e-04 | 173 | 75 | 4 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 174 | 75 | 4 | 44c21521991ad4789783d73d5aa4993a22876886 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 174 | 75 | 4 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 175 | 75 | 4 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 2.21e-04 | 176 | 75 | 4 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-04 | 176 | 75 | 4 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 2.26e-04 | 177 | 75 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 177 | 75 | 4 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.26e-04 | 177 | 75 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|tumor_Lung / Location, Cell class and cell subclass | 2.31e-04 | 178 | 75 | 4 | c57f92e57548638f1627dc7d313137f406dbecff | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 179 | 75 | 4 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-04 | 179 | 75 | 4 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.41e-04 | 180 | 75 | 4 | a0b35067b6f2dbd8145da8bab760e9f650f045b0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-04 | 180 | 75 | 4 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 2.41e-04 | 180 | 75 | 4 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-04 | 182 | 75 | 4 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.57e-04 | 183 | 75 | 4 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 2.57e-04 | 183 | 75 | 4 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epi_progenitor|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.57e-04 | 183 | 75 | 4 | 031b4ffd95114dc10d2932c67d2cfef139b3fd2e | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.57e-04 | 183 | 75 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.57e-04 | 183 | 75 | 4 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 184 | 75 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 184 | 75 | 4 | 9cbfb9f09476b4d09eb8f92c6f21e449dabcfa98 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 184 | 75 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 184 | 75 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 184 | 75 | 4 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-04 | 185 | 75 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.68e-04 | 185 | 75 | 4 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.68e-04 | 185 | 75 | 4 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.68e-04 | 185 | 75 | 4 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.68e-04 | 185 | 75 | 4 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | tumor_Lung-B_lymphocytes|tumor_Lung / Location, Cell class and cell subclass | 2.73e-04 | 186 | 75 | 4 | a54b368d7921185c583e35b532a6898c5486c2fc | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 186 | 75 | 4 | 2fab7abed16a894afdd0207e86fc43a25a77fb9e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 186 | 75 | 4 | ea2c8e0df038a00062d2098b4a9ac85141b9a728 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.73e-04 | 186 | 75 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-04 | 186 | 75 | 4 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.73e-04 | 186 | 75 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 186 | 75 | 4 | 714765585a644bf9817ab6eb3001b43b3c2d2410 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.79e-04 | 187 | 75 | 4 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.79e-04 | 187 | 75 | 4 | ab6f4d387218b4651fdadbf269806c1ddc96a1d2 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.79e-04 | 187 | 75 | 4 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-04 | 187 | 75 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-04 | 187 | 75 | 4 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.85e-04 | 188 | 75 | 4 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-04 | 188 | 75 | 4 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-04 | 188 | 75 | 4 | 2b8d70f761eda5509f21845a87cdb3602a639dd7 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.90e-04 | 189 | 75 | 4 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-04 | 190 | 75 | 4 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-04 | 190 | 75 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-04 | 190 | 75 | 4 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-04 | 191 | 75 | 4 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-04 | 191 | 75 | 4 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-04 | 191 | 75 | 4 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-04 | 192 | 75 | 4 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.08e-04 | 192 | 75 | 4 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 3.14e-04 | 193 | 75 | 4 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 3.14e-04 | 193 | 75 | 4 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-04 | 193 | 75 | 4 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 194 | 75 | 4 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 3.21e-04 | 194 | 75 | 4 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.21e-04 | 194 | 75 | 4 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 194 | 75 | 4 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| Drug | Chloroprene | SELL SPTLC3 NDNF CASP8AP2 SP100 THBS1 AFAP1L2 AKAP9 ZFHX4 SFTPB CYSLTR1 UCHL1 KRT85 IRAG2 MGA F5 | 5.36e-06 | 1348 | 74 | 16 | ctd:D002737 |
| Drug | geldanamycin | 2.72e-05 | 371 | 74 | 8 | ctd:C001277 | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 3.50e-05 | 189 | 74 | 6 | 5084_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 3.72e-05 | 191 | 74 | 6 | 4289_DN | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.94e-05 | 193 | 74 | 6 | 3880_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 4.06e-05 | 194 | 74 | 6 | 4320_DN | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A | 4.17e-05 | 195 | 74 | 6 | 4742_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 3214_UP | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 7440_UP | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 4.42e-05 | 197 | 74 | 6 | 1042_UP | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 6216_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 74 | 6 | 5494_DN | |
| Drug | petasiphenol | 4.85e-05 | 22 | 74 | 3 | CID006438779 | |
| Disease | Adenoid Cystic Carcinoma | 4.72e-06 | 100 | 72 | 5 | C0010606 | |
| Disease | hepatitis (biomarker_via_orthology) | 3.51e-05 | 4 | 72 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | obstructive sleep apnea (is_marker_for) | 4.86e-05 | 29 | 72 | 3 | DOID:0050848 (is_marker_for) | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 5.24e-04 | 14 | 72 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | Prostate cancer, familial | 6.50e-04 | 69 | 72 | 3 | C2931456 | |
| Disease | monocyte count | 1.33e-03 | 1320 | 72 | 10 | EFO_0005091 | |
| Disease | neuropsychological test | 1.39e-03 | 197 | 72 | 4 | EFO_0003926 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.57e-03 | 24 | 72 | 2 | C0345905 | |
| Disease | stomach carcinoma (is_marker_for) | 1.57e-03 | 24 | 72 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.57e-03 | 24 | 72 | 2 | C3805278 | |
| Disease | Myocardial Infarction | 1.64e-03 | 95 | 72 | 3 | C0027051 | |
| Disease | interstitial lung disease (is_marker_for) | 1.70e-03 | 25 | 72 | 2 | DOID:3082 (is_marker_for) | |
| Disease | Cholangiocarcinoma | 1.84e-03 | 26 | 72 | 2 | C0206698 | |
| Disease | lean mass-adjusted fat body mass, femoral neck bone mineral density | 1.98e-03 | 27 | 72 | 2 | EFO_0007785, EFO_0009890 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECRGNVAKEEVANKP | 181 | Q86US8 | |
| EKNENESCADRDTPQ | 736 | A6H8Y1 | |
| PALKCEVNAEDKENS | 1216 | Q99996 | |
| KCETNSVFDKQNDDP | 26 | Q9P2B7 | |
| QSPRNKIDEKCVQDE | 166 | Q9BXY5 | |
| ADNSCDKQQRARKLD | 201 | Q9BXY5 | |
| GQCIINSNKDDRPKD | 311 | P43652 | |
| VEKFLSDKNNPDVCD | 136 | Q15327 | |
| DAQRFNCQKPDIAEK | 286 | Q8N4X5 | |
| CLKENEQSKENEQSP | 326 | O75952 | |
| EDNCKEEKAQVANRP | 1771 | Q9UKL3 | |
| PETNCDVKDRQGKEQ | 751 | Q96QP1 | |
| NRKCQEQAVSPKVDD | 326 | Q5T7V8 | |
| EEACEKKDPATQQAF | 246 | Q9H6Z4 | |
| NDENEEKENNRASKP | 41 | Q33E94 | |
| LCSDVERQKNPENSK | 1171 | Q14207 | |
| EKDINNNVEKAPCAT | 21 | P35228 | |
| ESRKQEKACEQPALA | 71 | Q9BWK5 | |
| NEAAKPRNTEKDSNA | 386 | Q5TC84 | |
| IDQAPERSKEDANCA | 331 | Q8NEZ4 | |
| KNDENKDNVDTPCSQ | 2841 | Q8NEZ4 | |
| QSNLQPEAKEKECGD | 2151 | Q8IWI9 | |
| RKEDDDECLEQKPAQ | 416 | A5PLN7 | |
| EIDPNAQCVKQEEKE | 111 | P78386 | |
| KTEQENEAKCRNSKP | 266 | P83111 | |
| KPNKDLESCSDDDNQ | 121 | Q5T3I0 | |
| EGPSESKINCRDNKD | 1366 | O75369 | |
| EDQKKREQNQCLGPD | 491 | Q8TB73 | |
| DGEPNNKKNKEDCVE | 116 | P14151 | |
| DCQATEKILEENPKF | 1201 | Q8NG31 | |
| KDEEKANYCPVQNDL | 1351 | Q8NG31 | |
| AQDENCKSTKRAIEP | 131 | P54826 | |
| EFNNKREEHPEKCRS | 786 | Q86XP1 | |
| QAFVQKDPLDNDKSC | 231 | Q0VAM2 | |
| PEQDRCEASEQKQKV | 531 | Q9Y6X9 | |
| SPKVTFECEQKEENQ | 896 | P38398 | |
| NQCLDKATEEDSQVP | 521 | Q10472 | |
| DNKEGQEPAKRRSEC | 756 | Q8NHM5 | |
| SPSDCQEENAVDVKQ | 651 | Q8TF40 | |
| NCERIKLNTEENKPS | 1236 | O75417 | |
| PTARKQRKNQDDDDD | 71 | Q8IXQ4 | |
| EEEQERLKGCENKQP | 231 | Q3MJ40 | |
| KTQSNNAENKRPEED | 426 | Q7KZI7 | |
| YNSEKNQPTEEKVDC | 331 | P20933 | |
| FNPLEDDDDCQIKKR | 346 | Q12912 | |
| NSNRCHQETPKEDKE | 856 | Q9ULK0 | |
| EEEQERLKGCENKQP | 231 | A2RUR9 | |
| KQEAKEPAQCTEQAT | 516 | O75363 | |
| NENSVKEPEIRCDEK | 301 | Q13029 | |
| QNRPDECKSEGQSAK | 976 | Q5THK1 | |
| KVTQEPDINKDCDRE | 326 | Q6S8J7 | |
| DREKCKQFVEQHTPQ | 331 | P07988 | |
| DNINKFCENPDEVKR | 561 | P12259 | |
| ECDQFQKEQSPANRK | 1911 | Q8N4C6 | |
| CNAAVERKEQKDFVP | 91 | Q9NUV7 | |
| EKRKSPCESNNENDE | 11 | Q5VSR9 | |
| ERQQDESAPADKQCK | 511 | O94818 | |
| DTRSEQDKCNREPSK | 571 | Q02040 | |
| DEKNNTKCFEPPQDN | 166 | Q9Y271 | |
| IHQSDEQKLEKPNEC | 811 | Q70EK8 | |
| DCNQVDKPSDRGKRA | 156 | Q5T6F2 | |
| SESKDQENNCERPKE | 436 | Q86UP3 | |
| DKDNCRLVPNPDQKD | 906 | P07996 | |
| QQDAKAEENKKEPLC | 171 | O14562 | |
| CKKNEENEDSVFQPN | 831 | Q6AWC2 | |
| QEETGQRKECSTEPK | 176 | A8MU46 | |
| FCENTEPRSLQDKQK | 856 | Q9Y5W7 | |
| KESKIRDCEDPNNFS | 526 | O75038 | |
| KCVENTENKNVEFPN | 561 | Q9BX26 | |
| EHPCETEQINAKRKD | 206 | P23497 | |
| EPDKNADLQRFQRDC | 596 | Q9HBJ7 | |
| EDCTPQRDADKVNNE | 181 | O43657 | |
| NPEDLECNENVKHKT | 2526 | Q9BYW2 | |
| DERNCNKVTTAPKEN | 151 | Q09FC8 | |
| DDEHTRKCGENQNKP | 121 | Q5JVG2 | |
| QNEQKKTFARECDPD | 891 | Q5VWN6 | |
| KQACPQCKEDFDSQE | 661 | Q2M1K9 | |
| KRPSTVDKCEDSQEQ | 2311 | Q9BXT5 | |
| PEDRAKCFEKNEAIQ | 126 | P09936 |